Abstract Background and Aim Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) is a
novel fibrosis marker. We examined the ability of M2BPGi to predict liver fibrosis in patients …

Abstract Purpose The Mac-2-binding protein glycosylation-modified isomer (M2BPGi) is a
new marker for progression of hepatic fibrosis. We examined the relationship between …

Background Mild‐to‐moderate fibrosis is rarely diagnosed because the disease is
asymptomatic in the early stage. The serum level of Mac‐2 binding protein glycosylation …

Mac‐2 binding protein glycosylation isomer (M2BPGi) is a novel liver fibrosis biomarker, but
there are few studies on M2BPGi in liver transplantation (LT) recipients. This study aimed to …

Abstract Background and Aim Serum Mac‐2 binding protein glycosylation isomer (M2BPGi)
is a novel fibrosis marker for various chronic liver diseases. We investigated the ability of …

Background Mac-2 binding protein glycosylation isomer (M2BPGi) has been established as
a non-invasive biomarker for liver fibrosis. We evaluated the diagnostic efficacy of M2BPGi …

Abstract Background Mac-2 Binding Protein Glycosylation isomer (M2BPGi) is a novel
serological glyco-biomarker for staging liver fibrosis. Here, we aimed to evaluate the …

An accurate evaluation of liver fibrosis is clinically important in chronic liver diseases. Mac-2
binding protein glycosylation isomer (M2BPGi) is a novel serum marker for liver fibrosis. In …

Background The accurate evaluation of liver fibrosis is crucial for the treatment and follow up
of chronic hepatitis B (CHB) patients. Aim We examined the efficiency of serum Mac-2 …

Objective: The aim of this study was to evaluate the usefulness of the Mac-2 binding protein
glycosylation isomer (M2BPGi) for the prediction of posthepatectomy liver failure (PHLF) in …